English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
  Elucidation of the Influenza A Virus Glycosylation Patterns with Respect to Vaccine Production Down to the Lower Zeptomolar Range

Rapp, E., Schwarzer, J., & Reichl, U. (2007). Elucidation of the Influenza A Virus Glycosylation Patterns with Respect to Vaccine Production Down to the Lower Zeptomolar Range. Talk presented at 21st International Symposium on MicroScale Bioseparations (MSB). Vancouver, BC, Canada. 2007-01-14 - 2007-01-18.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Rapp, E.1, Author           
Schwarzer, J.2, Author           
Reichl, U.2, 3, Author           
Affiliations:
1Physical and Chemical Foundations of Process Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society, ou_1738150              
2Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society, ou_1738140              
3Otto-von-Guericke-Universität Magdeburg, ou_1738156              

Content

show
hide
Free keywords: -
 Abstract: The ability of monitoring and thereby controlling the glycosylation pattern of viral membrane-proteins during the vaccine production process, is a prerequisite for yield enhancement in vaccine production and to ensure sufficient immune-response after vaccination. The glycosylation pattern of viral glycoproteins can be affected by virus strain, host cell glycosylation machinery, cultivation conditions and via incipient degradation of the glycosylation during virus inactivation and downstream processing. The presented approach allows the characterization of N-glycosylation patterns, shown exemplarily on hemagglutinin of influenza A/PR/8/34(H1N1) virus, produced in MDCK-cells. The procedure includes: virus purification and concentration directly from cell-culture supernatant, followed by preparation, separation and identification of viral (glyco-)proteins and their N-glycan pools, utilizing: g-force-step-gradient-centrifugation, SDS-PAGE, enzymatical cleavage, fluorescent labeling, CGE-LIF (employing a DNA-sequenzer) and MALDI-TOF MS. The N-glycans are analyzed in two stages: glycome fingerprints and structural identification. Generation of fingerprints with CGE-LIF, enables LODs down to the lower zeptomolar range. Additional structural information are obtained, spiking the samples with a series of N-glycan standards, measured with CGE-LIF and MALDI-TOF MS. This proceeding enables monitoring of N-glycosylation patterns of relevant glycoproteins during major steps of up- and downstream processing in influenza virus vaccine production.

Details

show
hide
Language(s): eng - English
 Dates: 2007
 Publication Status: Not specified
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Identifiers: eDoc: 327344
Other: RappSchwarzerReichl2007
 Degree: -

Event

show
hide
Title: 21st International Symposium on MicroScale Bioseparations (MSB)
Place of Event: Vancouver, BC, Canada
Start-/End Date: 2007-01-14 - 2007-01-18

Legal Case

show

Project information

show

Source

show